# A Study to Evaluate the Safety and Tolerability of Multiple Intravenous Doses of MEDI 545 in Patients With Systemic Lupus Erythematosus

> **NCT00482989** · PHASE1 · COMPLETED · sponsor: **MedImmune LLC** · enrollment: 183 (actual)

## Conditions studied

- Lupus

## Interventions

- **BIOLOGICAL:** MEDI 545
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT00482989
- **Lead sponsor:** MedImmune LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-06
- **Primary completion:** 2010-07
- **Final completion:** 2010-09
- **Target enrollment:** 183 (ACTUAL)
- **Last updated:** 2012-07-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00482989

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00482989, "A Study to Evaluate the Safety and Tolerability of Multiple Intravenous Doses of MEDI 545 in Patients With Systemic Lupus Erythematosus". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00482989. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*